Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Innate Pharma S.A. Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024 January 12, 2024 From Innate Pharma S.A. Via Business Wire Tickers IPHA Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer June 03, 2022 From Innate Pharma S.A. Via Business Wire Tickers IPHA Outcome of Innate Pharma’s 2022 Annual General Meeting May 20, 2022 From Innate Pharma S.A. Via Business Wire Tickers IPHA Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022 January 24, 2022 From Innate Pharma S.A. Via Business Wire Tickers IPHA Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress December 09, 2021 From Innate Pharma S.A. Via Business Wire Tickers IPHA Innate Pharma Third Quarter 2021 Report November 16, 2021 From Innate Pharma S.A. Via Business Wire Tickers IPHA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.